Two new studies have cast unprecedented light on disease processes in tuberculosis, identifying key genetic changes that cause damage in the lungs and a drug treatment that could
A team of researchers from the Agency for Science, Technology and Research’s (A*STAR) Genome Institute of Singapore (GIS) and Bioprocessing Technology Institute (BTI), as well as Singapore Eye
Professor Chunghun Lim and his research team in the Department of Biological Sciences unveiled a neuroprotective pathway that suppresses Lou Gehrig’s Disease (ALS). Nucleocytoplasmic transport (NCT) defects have
Cancerous cells exhibit several key differences from healthy cells that help identify them as dangerous. For instance, the pH—the level of acidity—within a cancerous cell is not the
Cancerous cells exhibit several key differences from healthy cells that help identify them as dangerous. For instance, the pH—the level of acidity—within a cancerous cell is not the
Researchers from the Barbara Davis Center for Childhood Diabetes at the University of Colorado Anschutz Medical Campus have found that immune responses to insulin could help identify individuals
The earliest eye damage from prion disease takes place in the cone photoreceptor cells, specifically in the cilia and the ribbon synapses, according to a new study of
Scientists from the Max Planck Institute of Psychiatry, led by Nikolaos Koutsouleris, combined psychiatric assessments with machine-learning models that analyze clinical and biological data. Although psychiatrists make very
There are 86 billion neurons, or cells, in the human brain. Of these, an infinitely small portion of them handle cognitive flexibility—our ability to adjust to new environments
Researchers have found drug fragments, which could help improve our understanding of the function of a key cancer protein and ultimately lead to new drug treatments. The drug
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
